CClinicalTrials.gg
CompletedNCT00793299Updated Apr 27, 2015

Burden of Cancer in Children: A Pilot Study to Investigate the Impact and Content of Video Illness Narratives

An interventional study of Video Illness Narrative in Cancer, sponsored by University of Rochester. Completed at 1 site in United States. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2015-04-27.

Sponsored by University of Rochester · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
10 Years to 18 Years
Sex
All
01

Study summary

In order to gain a greater understanding of the full experience of children with life-threatening illness, this study will provide video cameras to ten to fifteen 10-18 years olds in active treatment for cancer, and instruct them to make video illness narratives over the course of 1-3 months. The narratives will be studied as an intervention; each of the participants will be administered a measure of physical symptoms (the Memorial Symptom Assessment scale 10-18) and a measure of self-esteem (the Rosenberg Self-Esteem Scale). The video narratives will also be analyzed for content by theme in order to understand the participants' experiences in their own words. Our hypothesis is that these narratives will provide insight into the lives of children with cancer, increase their self-esteem, and decrease symptom distress, and improve communication between patients and their doctors.

Read the detailed description

In addition to the above outcome measures:

The video narratives will also be analyzed for content by theme in order to understand the participants' experiences in their own words.

02

Conditions studied

  • Cancer
03

In context

Lead sponsor

University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed with cancer
  • Age 10-18
  • In active treatment for cancer
  • Followed at the Strong Memorial Hospital/Golisano Children's Hospital

Exclusion criteria

Exclusion Criteria:

  • Non-English Speaker
  • Cognitively impaired so as to make data collection difficult
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Video Illness Narrative

    single arm pilot study

    Behavioral: Video Illness Narrative

Interventions

  • BehavioralVideo Illness Narrative

    video

06

What researchers measure

Primary outcomes

  1. Memorial Symptom Assessment Scale

    Time frame: 3 months

Secondary outcomes

  1. Rosenberg Self Esteem Scale

    Time frame: 3 mopnths

07

Study locations

1 site
  • University of Rochester School of Medicine and Dentistry, Golisano Children's Hospital at Strong
    Rochester, New York 14642, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00793299
Lead sponsor
University of Rochester
Responsible party
Barbara Asselin (Pediatrics, Hematology Oncology, University of Rochester) — Principal investigator
First posted
Nov 19, 2008
Start date
Nov 2008
Primary completion
Jun 2009
Completion
Sep 2009
Last update
Apr 27, 2015

Study contacts

Emily Hahn, BA
principal investigator · Medical Student
Barbara Asselin, MD
principal investigator · Associate Professor

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion